|
December 6, 2005 Categories: Blogroll Posted by admin
Federal regulators have approved Boston Scientific’s new Liberte heart stent, the company said Thursday.
Boston Scientific hopes sales of Liberte, a bare-metal stent that is not coated with drugs, will supplement Taxus Express2, the drug-coated stent credited with driving the medical device maker’s 62 percent sales growth last year.
Full news
|
|
